(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -35.15%54.87M | 54.95%140.3M | 178.02%84.61M | -41.79%90.54M | -79.11%30.43M | -24.74%155.54M | -22.32%145.65M | -60.08%206.67M | -7.34%187.49M | 106.52%517.67M |
Operating income | -35.15%54.87M | 54.95%140.3M | 178.02%84.61M | -41.79%90.54M | -79.11%30.43M | -24.74%155.54M | -22.32%145.65M | -60.08%206.67M | -7.34%187.49M | 106.52%517.67M |
Cost of sales | 34.14%-48.6M | -50.92%-125.49M | -162.45%-73.8M | 45.27%-83.15M | 79.73%-28.12M | 30.63%-151.91M | 24.99%-138.69M | 56.78%-218.98M | 5.61%-184.91M | -102.08%-506.65M |
Operating expenses | 34.14%-48.6M | -50.92%-125.49M | -162.45%-73.8M | 45.27%-83.15M | 79.73%-28.12M | 30.63%-151.91M | 24.99%-138.69M | 56.78%-218.98M | 5.61%-184.91M | -102.08%-506.65M |
Gross profit | -42.02%6.27M | 100.24%14.81M | 367.08%10.81M | 103.92%7.4M | -66.73%2.32M | 129.45%3.63M | 169.10%6.96M | -211.76%-12.32M | -59.87%2.59M | 18,163.93%11.02M |
Selling expenses | 39.80%-3.73M | -82.46%-10.81M | -701.55%-6.19M | -95.90%-5.92M | 25.91%-772K | 58.94%-3.02M | 60.21%-1.04M | 9.98%-7.36M | -247.35%-2.62M | -181.42%-8.18M |
Administrative expenses | -32.35%-16.77M | -27.33%-40.75M | 14.20%-12.67M | -0.87%-32.01M | 1.36%-14.77M | 68.69%-31.73M | 46.56%-14.97M | -51.44%-101.34M | -120.48%-28.02M | 70.03%-66.92M |
Impairment and provision | ---- | -2,112.59%-14.76M | ---- | 96.99%-667K | ---- | -85.83%-22.2M | ---- | 85.41%-11.94M | ---- | ---81.84M |
-Other impairment is provision | ---- | -2,112.59%-14.76M | ---- | 96.99%-667K | ---- | -85.83%-22.2M | ---- | 85.41%-11.94M | ---- | ---81.84M |
Special items of operating profit | 24.39%8.05M | -1,227.89%-744.32M | 581.77%6.48M | -365.93%-56.05M | -122.28%-1.34M | -48.37%21.08M | 157.94%6.03M | 607.17%40.83M | -193.20%-10.41M | -81.12%5.77M |
Operating profit | -292.56%-6.18M | -812.11%-795.83M | 89.20%-1.57M | -170.60%-87.25M | -381.69%-14.57M | 65.01%-32.24M | 92.13%-3.03M | 34.25%-92.14M | -1,026.50%-38.46M | 28.39%-140.15M |
Financing cost | -35.29%-10.14M | 60.97%-20.53M | 78.64%-7.49M | 22.99%-52.59M | 5.77%-35.09M | 46.19%-68.28M | -3.73%-37.24M | 14.18%-126.91M | 30.44%-35.9M | -43.27%-147.88M |
Earning before tax | -79.93%-16.31M | -483.79%-816.35M | 81.74%-9.07M | -39.10%-139.84M | -23.34%-49.66M | 54.11%-100.53M | 45.85%-40.26M | 23.95%-219.05M | -56.69%-74.36M | 22.25%-288.03M |
Tax | 97.81%-4K | 104.68%31K | 70.53%-183K | ---662K | ---621K | ---- | ---- | ---- | ---- | -63.57%419K |
After-tax profit from continuing operations | -76.41%-16.32M | -481.02%-816.32M | 81.60%-9.25M | -39.76%-140.5M | -24.89%-50.28M | 54.11%-100.53M | 45.85%-40.26M | 23.84%-219.05M | -56.69%-74.36M | 22.12%-287.61M |
Earning after tax | -76.41%-16.32M | -481.02%-816.32M | 81.60%-9.25M | -39.76%-140.5M | -24.89%-50.28M | 54.11%-100.53M | 45.85%-40.26M | 23.84%-219.05M | -56.69%-74.36M | 22.12%-287.61M |
Minority profit | -296.60%-1.52M | ---4.93M | ---382K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -66.93%-14.8M | -477.51%-811.39M | 82.36%-8.87M | -39.76%-140.5M | -24.89%-50.28M | 54.11%-100.53M | 45.85%-40.26M | 23.84%-219.05M | -56.69%-74.36M | 22.12%-287.61M |
Basic earnings per share | -51.85%-0.0041 | 88.89%-0.24 | 99.70%-0.0027 | 3.57%-2.16 | 11.60%-0.9105 | 70.49%-2.24 | -232.26%-1.03 | -389.68%-7.59 | -19.23%-0.31 | 28.24%-1.55 |
Diluted earnings per share | -51.85%-0.0041 | 88.89%-0.24 | 99.70%-0.0027 | 3.57%-2.16 | 11.60%-0.9105 | 70.49%-2.24 | -232.26%-1.03 | -389.68%-7.59 | -19.23%-0.31 | 28.24%-1.55 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data